Bioreactor Systems for Tissue Engineering

The editors of this special volume would first like to thank all authors for their excellent contributions. We would also like to thank Prof. Dr. Thomas Scheper, Dr. Marion Hertel and Ulrike Kreusel for providing the opportunity to compose this volume and Springer for organizational and technical su...

Πλήρης περιγραφή

Λεπτομέρειες βιβλιογραφικής εγγραφής
Συγγραφή απο Οργανισμό/Αρχή: SpringerLink (Online service)
Άλλοι συγγραφείς: Kasper, Cornelia (Επιμελητής έκδοσης), Griensven, Martijn van (Επιμελητής έκδοσης), Pörtner, Ralf (Επιμελητής έκδοσης)
Μορφή: Ηλεκτρονική πηγή Ηλ. βιβλίο
Γλώσσα:English
Έκδοση: Berlin, Heidelberg : Springer Berlin Heidelberg, 2009.
Σειρά:Advances in Biochemical Engineering/Biotechnology, 112
Θέματα:
Διαθέσιμο Online:Full Text via HEAL-Link
LEADER 04403nam a22005535i 4500
001 978-3-540-69357-4
003 DE-He213
005 20151110151212.0
007 cr nn 008mamaa
008 100301s2009 gw | s |||| 0|eng d
020 |a 9783540693574  |9 978-3-540-69357-4 
024 7 |a 10.1007/978-3-540-69357-4  |2 doi 
040 |d GrThAP 
050 4 |a TP248.13-248.65 
072 7 |a TCB  |2 bicssc 
072 7 |a SCI010000  |2 bisacsh 
082 0 4 |a 660.6  |2 23 
245 1 0 |a Bioreactor Systems for Tissue Engineering  |h [electronic resource] /  |c edited by Cornelia Kasper, Martijn van Griensven, Ralf Pörtner. 
264 1 |a Berlin, Heidelberg :  |b Springer Berlin Heidelberg,  |c 2009. 
300 |a XII, 271 p. 77 illus., 16 illus. in color.  |b online resource. 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a text file  |b PDF  |2 rda 
490 1 |a Advances in Biochemical Engineering/Biotechnology,  |x 0724-6145 ;  |v 112 
505 0 |a Bioreactors in Tissue Engineering: Scientific Challenges and Clinical Perspectives -- Bioreactor Technology in Cardiovascular Tissue Engineering -- Bioreactors for Guiding Muscle Tissue Growth and Development -- Bioreactors for Connective Tissue Engineering: Design and Monitoring Innovations -- Mechanical Strain Using 2D and 3D Bioreactors Induces Osteogenesis: Implications for Bone Tissue Engineering -- Bioreactors for Tissue Engineering of Cartilage -- Technical Strategies to Improve Tissue Engineering of Cartilage-Carrier-Constructs -- Application of Disposable Bag Bioreactors in Tissue Engineering and for the Production of Therapeutic Agents -- Methodology for Optimal In Vitro Cell Expansion in Tissue Engineering -- Bioreactor Studies and Computational Fluid Dynamics -- Fluid Dynamics in Bioreactor Design: Considerations for the Theoretical and Practical Approach. 
520 |a The editors of this special volume would first like to thank all authors for their excellent contributions. We would also like to thank Prof. Dr. Thomas Scheper, Dr. Marion Hertel and Ulrike Kreusel for providing the opportunity to compose this volume and Springer for organizational and technical support. Tissue engineering represents one of the major emerging fields in modern b- technology; it combines different subjects ranging from biological and material sciences to engineering and clinical disciplines. The aim of tissue engineering is the development of therapeutic approaches to substitute diseased organs or tissues or improve their function. Therefore, three dimensional biocompatible materials are seeded with cells and cultivated in suitable systems to generate functional tissues. Many different aspects play a role in the formation of 3D tissue structures. In the first place the source of the used cells is of the utmost importance. To prevent tissue rejection or immune response, preferentially autologous cells are now used. In particular, stem cells from different sources are gaining exceptional importance as they can be differentiated into different tissues by using special media and supplements. In the field of biomaterials, numerous scaffold materials already exist but new composites are also being developed based on polymeric, natural or xenogenic sources. Moreover, a very important issue in tissue en- neering is the formation of tissues under well defined, controlled and reprod- ible conditions. Therefore, a substantial number of new bioreactors have been developed. 
650 0 |a Chemistry. 
650 0 |a Human genetics. 
650 0 |a Medical microbiology. 
650 0 |a Molecular biology. 
650 0 |a Biotechnology. 
650 0 |a Biochemistry. 
650 1 4 |a Chemistry. 
650 2 4 |a Biotechnology. 
650 2 4 |a Human Genetics. 
650 2 4 |a Molecular Medicine. 
650 2 4 |a Medical Microbiology. 
650 2 4 |a Biochemistry, general. 
700 1 |a Kasper, Cornelia.  |e editor. 
700 1 |a Griensven, Martijn van.  |e editor. 
700 1 |a Pörtner, Ralf.  |e editor. 
710 2 |a SpringerLink (Online service) 
773 0 |t Springer eBooks 
776 0 8 |i Printed edition:  |z 9783540693567 
830 0 |a Advances in Biochemical Engineering/Biotechnology,  |x 0724-6145 ;  |v 112 
856 4 0 |u http://dx.doi.org/10.1007/978-3-540-69357-4  |z Full Text via HEAL-Link 
912 |a ZDB-2-CMS 
950 |a Chemistry and Materials Science (Springer-11644)